Non-invasive
prenatal testing (NIPT) is used for screening pregnant women at high
risk of developing fetal chromosomal aneuploidies such as Down
syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome
(trisomy 13), and Turner syndrome (monosomy X), and also for fetal
sex determination. Until recently, amniocentesis, chorionic villus
sampling (CVS), maternal serum screening and nuchal translucency (NT)
scan were the primary diagnostic and screening methods for
chromosomal abnormalities. Advent of non-invasive prenatal test is
poised to eliminate disadvantages associated with these methods, such
as low rate of accuracy with maternal serum screening and NT scan,
and risk of miscarriage with invasive amniocentesis and CVS
procedures. This report on non-invasive prenatal testing market
studies the current market scenario and future potential for
non-invasive prenatal tests globally. The major non-invasive prenatal
tests studied in this report are BambniTest, Harmony, informaSeq,
MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi, VisibiliT and
others (IONA, NACE, etc.). These tests have been extensively analyzed
on the basis of factors such as the technology used, cost to
patients, reimbursement coverage, accuracy and geographical reach
(availability across various countries). The historical market size
and forecast for each of these tests in terms of revenue (USD
Million) and volume (Number of tests performed) have been given in
the report for the period 2012 to 2022. In addition, the compounded
annual growth rate (CAGR) of the overall non-invasive prenatal test
market and the above tests has also been provided in the report for
the forecast period 2014 to 2022, considering 2012 and 2013 as the
base years. The report on non-invasive prenatal testing market also
provides comparative analysis of major tests for the years 2013 and
2022.
Browse
full
report
at :
http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html
In this research
study, the global market for non-invasive prenatal testing has been
geographically segmented into four regions, namely, North America,
Europe, Asia-Pacific and Rest of the World (RoW). The non-invasive
prenatal testing market size and forecast in terms of revenue (USD
Million) and volume (Number of Tests Performed) for each region has
been provided for the period 2012 to 2022 along with the CAGR for the
forecast period 2014 to 2022. The non-invasive prenatal testing
market study also includes qualitative analysis of the competitive
scenario in these regions such as major collaboration and
partnership, entry of new entrants, new product launch and other
macro economic factors. The market overview section of the report on
non-invasive prenatal testing market comprises qualitative analysis
of the overall non-invasive prenatal testing market considering the
factors determining the market dynamics such as drivers, restraints
and opportunities along with the Porter’s five force analysis and
market attractiveness analysis. The market overview chapter also
provides information such as major chromosomal aneuploidies (Down
syndrome, Edwards syndrome, Patau syndrome and monosomy X, and their
incidence rate, technological approach for NIPT and major patents
issued to players operating in the market and other companies and
academic research institutions.
Browse the full Press Release:
http://www.transparencymarketresearch.com/pressrelease/noninvasive-prenatal-diagnostics-market.htm
The report also
includes a section on the competitive landscape of the market,
wherein the market share analysis of leading players in the global
non-invasive prenatal testing market, in terms of percentage share in
2013 has been discussed. A list of recommendations has also been
included for new entrants as well as existing market players to help
them establish a strong presence in the non-invasive prenatal testing
market and accentuate market shares. The report concludes with the
profiles of major players in the NIPT market such as Sequenom, Inc.,
Ariosa Diagnostics, Natera, Inc., Illumina, Inc. (Verinata Health,
Inc.), BGI Diagnostics, LifeCodexx AG, Laboratory Corporation of
America Holdings (LabCorp) and Berry Genomics. Each company profile
comprises information such as company overview, financial overview,
product portfolio, business strategies and recent developments.
The global
non-invasive prenatal testing market is segmented as follows:
Global Non-Invasive
Prenatal Testing Market, by Test
BambniTest
Harmony
informaSeq
MaterniT21 PLUS
NIFTY
Panorama
PrenaTest
verifi
VisibiliT
Others
Global Non-Invasive
Prenatal Testing Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World
(RoW)
Request
a Brochure of this :
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=374
About
Us
Transparency
Market Research (TMR) is a global market intelligence company
providing business information reports and services. The company’s
exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants
use proprietary data sources and various tools and description
techniques to gather and analyze information.
TMR’s
data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and
information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary
research techniques to develop distinctive data sets and research
material for business reports.
Contact
Mr.
Nachiket Ghumare
90
State Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
No comments:
Post a Comment